Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke

American Medical Association, JAMA Cardiology, 7(7), p. 682, 2022

Journal article published in 2022 by M. Cecilia Bahit, Amit N. Vora, Zhuokai Li, Daniel M. Wojdyla, Laine Thomas, Shaun G. Goodman, Ronald Aronson, J. Dedrick Jordan, Brad J. Kolls, Keith E. Dombrowski, Dragos Vinereanu, Sigrun Halvorsen, Otavio Berwanger, Stephan Windecker, Roxana Mehran and other authors.

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by